Cerebroprotein Hydrolysate for Injection 30mg

Recovery after a stroke or a serious head injury is rarely a straight line, and a lot of what neurologists are actually trying to do in those early weeks is give the brain's own repair mechanisms a better chance to work. Cerebroprotein Hydrolysate for Injection is built around that idea. It is a peptide-based neurotrophic agent derived from purified brain protein, used to support nerve cell recovery and protect neurons from further damage during acute and chronic brain-related conditions. The 30mg strength delivers a lower-nitrogen-equivalent dose commonly used in less severe cases, in pediatric and lower body weight patients, or as a starting dose in treatment protocols that scale up gradually. Clinically, this category of injectable is used across a range of neurological situations, including stroke rehabilitation, traumatic brain injury recovery, and cognitive decline associated with conditions like Alzheimer's disease, where supporting neuronal survival and synaptic function is part of the broader treatment strategy alongside physical and cognitive rehabilitation. For hospitals and neurology-focused clinics building out a rehabilitation and neuroprotection formulary, having a reliable, well-documented source for this category of injectable matters more than it might for a more commoditized product, simply because fewer manufacturers specialize in it. Sara Wellness has spent fifteen years building direct relationships with GMP-certified Indian manufacturers across a wide therapeutic range, including specialized neurology injectables like this one, and we bring the same documentation discipline to this product that we apply to our critical care antibiotic lines. We work one on one with hospital procurement teams, rehabilitation centers, and distributors rather than routing orders through intermediaries who add cost without adding value. That direct relationship matters particularly for a specialized neurology product, where questions about dosing protocols, batch consistency, and regulatory documentation tend to be more technical than a standard antibiotic order. Our MOQs are set to work for smaller neurology clinics testing this product for the first time as well as larger hospital networks incorporating it into standing stroke and brain injury protocols. Every shipment ships with certificate of analysis, GMP compliance documentation, and export paperwork prepared for your destination country's specific regulatory requirements. If your hospital, rehabilitation center, or distribution business is looking to add a dependable source for Cerebroprotein Hydrolysate to your neurology portfolio, reach out with your target country and expected order size and we will respond with current pricing and realistic delivery timelines.